| H2Q-MC-LZZT Baseline/First Study Treatment Visit |
| 2.0.0-snapshot |
| VISIT-3 |
| urn:oid:2.16.840.1.113883.4.642.40.224.34.4 |
|
World
|
| HL7 International / Biomedical Research and Regulation |
| HL7 International / Biomedical Research and Regulation |
|
clinical-protocol from http://terminology.hl7.org/CodeSystem/plan-definition-type
|
| VISIT-3-H2Q-MC-LZZT-Visit-Date |
| Record Visit Date |
| ActivityDefinition/H2Q-MC-LZZT-Visit-Date |
| Vital signs: Weight |
| PlanDefinition/H2Q-MC-LZZT-Vital-Signs-Weight-PD |
| Vital Signs: Temperature |
| PlanDefinition/H2Q-MC-LZZT-Vital-Signs-Temperature-PD |
| Vital Signs: Heart Rate and Blood Pressure |
| ActivityDefinition/H2Q-MC-LZZT-Vital-Signs-HeartRate-BloodPressure |
| Ambulatory ECG removed |
| ActivityDefinition/H2Q-MC-LZZT-Ambulatory-ECG-removed |
| Concomitant Medications |
| ActivityDefinition/H2Q-MC-LZZT-Concomitant-Medications |
| VISIT-3-H2Q-MC-LZZT-Patient-randomized |
| Patient randomized |
| ActivityDefinition/H2Q-MC-LZZT-Patient-randomized |
| Plasma Specimen (Xanomeline) |
| ActivityDefinition/H2Q-MC-LZZT-Plasma-Specimen |
| Study drug record: Medications Dispensed/Returned |
| ActivityDefinition/H2Q-MC-LZZT-Study-drug-record |
| ADAS-Cog |
| ActivityDefinition/H2Q-MC-LZZT-ADAS-Cog |
| Clinician's Interview-Based Impression of Change |
| ActivityDefinition/H2Q-MC-LZZT-CIBIC |
| Disability Assessment for Dementia |
| ActivityDefinition/H2Q-MC-LZZT-DAD |
| Neuropsychiatric Inventory Questionnaire – Revised |
| ActivityDefinition/H2Q-MC-LZZT-NPI-X |
| Adverse events |
| ActivityDefinition/H2Q-MC-LZZT-Adverse-events |